Preprint / Version 1

Evaluating a novel Transcutaneous Auricular Vagus Nerve Stimulation control condition

##article.authors##

  • Yishai Valter Soterix Medical
  • Gunnar Turnquist Soterix Medical
  • Kamran Nazim Soterix Medical
  • Teresa J. Kimberley MGH Institute of Health Professions
  • Giuseppina Pilloni New York University Grossman School of Medicine
  • Leigh Charvet New York University Grossman School of Medicine
  • Bashar W. Badran
  • Abhishek Datta Soterix Medical

DOI:

https://doi.org/10.31224/5672

Keywords:

transcutaneous auricular vagus nerve stimulation, electrical stimulation, blinding, stroke

Abstract

Objective: Transcutaneous auricular vagus nerve stimulation (taVNS) is being actively explored as a therapeutic option for multiple conditions. Current blinding strategies employed in the literature are variable, and non-optimal due to perception confounds. Additional strategies are needed. We assessed the blinding integrity of taVNS when used with a novel sham waveform.

Methods: Ten healthy subjects (mean age: 36.6 ± 11.3 y) completed a randomized, double-blind, parallel study. taVNS was delivered while participants performed tasks mimicking upper limb rehabilitative training. The intervention consisted of 6, thirty-minute sessions over 2 weeks. The blinding assessment was performed after the last session.  

Results: Majority of the participants (n=6) were unsure of their stimulation allocation. The binomial test indicated no evidence of systematic unblinding based on guessing alone. Bang’s blinding index was -0.20 and -0.60 for the active and sham groups, respectively. 

Discussion: This study's sham taVNS protocol indicates satisfactory participant blinding. Testing on larger samples and clinical populations is advocated to further demonstrate utility.

Downloads

Download data is not yet available.

Downloads

Posted

2025-10-24